SMC2 and pancreatic adenocarcinoma: The results of DNA microarray analysis have revealed the upregulation of SMC4 expression in PAAD, compared to the case in normal tissues, and thus, SMC2/4 may be a potential target for effective broad-spectrum anticancer agents (21).